<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="8812">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00803114</url>
  </required_header>
  <id_info>
    <org_study_id>MSHREB 01-0227-A</org_study_id>
    <nct_id>NCT00803114</nct_id>
  </id_info>
  <brief_title>Epidural Morphine Following Vaginal Delivery</brief_title>
  <official_title>Epidural Morphine Following Vaginal Delivery: A Randomised, Double-Blind, Placebo-Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mount Sinai Hospital, Canada</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Physicians' Services Incorporated Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mount Sinai Hospital, Canada</source>
  <oversight_info>
    <authority>Canada: Health Canada</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators believe that pain management following a vaginal delivery can be improved.
      Many women receive epidural medication during labor and delivery, and the investigators felt
      that using the epidural following delivery might improve the first day pain. This study is
      to determine whether a single dose of epidural morphine given to mothers after a vaginal
      delivery will reduce the perineal pain in the postpartum period.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vaginal deliveries comprise 80-85% of all deliveries. Although this is felt to be natural
      and safe, this route can be associated with significant perineal trauma and subsequent
      postpartum perineal pain. The degree of perineal trauma varies from the minimum of vaginal
      stretching and distension associated with labor, to episiotomy and significant perineal
      tears. In spite of the differences in the degree of injury following vaginal delivery,
      postpartum pain therapy is poorly organized and at best consists of simple analgesics and
      anti-inflammatory drugs. The purpose of this study is to determine if a single dose of
      epidural-administered morphine offers additional advantage to an organized program for the
      management of immediate postpartum perineal pain following vaginal delivery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2002</start_date>
  <completion_date type="Actual">February 2005</completion_date>
  <primary_completion_date type="Actual">November 2004</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>The Number of Women Who Received Systemic Narcotic Analgesics in the First 24 Hours Postpartum</measure>
    <time_frame>24 hours postpartum</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to First Request for Analgesia</measure>
    <time_frame>Hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal Visual Analogue Scale (VAS) Score at Time of Request for First Additional Analgesic</measure>
    <time_frame>by 24 hours postpartum</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal Satisfaction With Perineal Pain Management</measure>
    <time_frame>at 24 hours postpartum</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side Effects</measure>
    <time_frame>at 24 hours postpartum</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">228</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Epidural Morphine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2.5 mg dose of epidural morphine given within one hour following vaginal delivery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>5 ml of epidural preservative-free saline given within one hour following vaginal delivery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Preservative-free epidural morphine</intervention_name>
    <description>One time dose of preservative-free epidural morphine 2.5 mg given within one hour following vaginal delivery</description>
    <arm_group_label>Epidural Morphine</arm_group_label>
    <other_name>Morphine</other_name>
    <other_name>Epidural Narcotics</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>5 ml of epidural preservative-free saline given within one hour following vaginal delivery</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy parturients (ASA 1 or 2) of &gt; 34 weeks gestational age who chose epidural
             analgesia for labor, and deliver vaginally.

        Exclusion Criteria:

          -  Women whose labor is terminated by cesarean delivery

          -  Parturients with known morphine allergy

          -  Parturients with narcotic addiction past / present
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alison J Macarthur, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Toronto</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mount Sinai Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1X5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Goodman SR, Drachenberg AM, Johnson SA, Negron MA, Kim-Lo SH, Smiley RM. Decreased postpartum use of oral pain medication after a single dose of epidural morphine. Reg Anesth Pain Med. 2005 Mar-Apr;30(2):134-9.</citation>
    <PMID>15765455</PMID>
  </reference>
  <reference>
    <citation>Macdonald R, Smith PJ. Extradural morphine and pain relief following episiotomy. Br J Anaesth. 1984 Nov;56(11):1201-5.</citation>
    <PMID>6386019</PMID>
  </reference>
  <reference>
    <citation>Niv D, Wolman I, Yashar T, Varrassi G, Rudick V, Geller E. Epidural morphine pretreatment for postepisiotomy pain. Clin J Pain. 1994 Dec;10(4):319-23.</citation>
    <PMID>7858363</PMID>
  </reference>
  <verification_date>December 2008</verification_date>
  <lastchanged_date>January 13, 2009</lastchanged_date>
  <firstreceived_date>November 7, 2008</firstreceived_date>
  <firstreceived_results_date>November 7, 2008</firstreceived_results_date>
  <responsible_party>
    <name_title>Dr. Alison Macarthur</name_title>
    <organization>University of Toronto</organization>
  </responsible_party>
  <keyword>Postpartum perineal pain</keyword>
  <keyword>Epidural morphine</keyword>
  <keyword>Randomised clinical trial</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Polystyrene sulfonic acid</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Parturients were recruited at Mount Sinai Hospital labor and delivery unit. Recruitment took place between March 2002 and November 2004.</recruitment_details>
      <pre_assignment_details>Parturients were approached prior to delivery if they had received epidural analgesia for labor. Following a vaginal delivery, the subject was randomized to one of the two arms.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Epidural Morphine</title>
          <description>2.5 mg dose of epidural morphine given within one hour following vaginal delivery</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>5 ml of epidural preservative-free saline given within one hour following vaginal delivery</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="113"/>
                <participants group_id="P2" count="115"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="113"/>
                <participants group_id="P2" count="115"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Epidural Morphine</title>
          <description>2.5 mg dose of epidural morphine given within one hour following vaginal delivery</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>5 ml of epidural preservative-free saline given within one hour following vaginal delivery</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="113"/>
                <measurement group_id="B2" value="115"/>
                <measurement group_id="B3" value="228"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="32.1" spread="4.9"/>
                <measurement group_id="B2" value="31.8" spread="4.9"/>
                <measurement group_id="B3" value="32.0" spread="4.9"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="113"/>
                <measurement group_id="B2" value="115"/>
                <measurement group_id="B3" value="228"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <description>Number of caucasian, non-caucasian study subjects</description>
          <units>Participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Caucasian</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="87"/>
                <measurement group_id="B2" value="99"/>
                <measurement group_id="B3" value="186"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Non-caucasian</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="17"/>
                <measurement group_id="B2" value="11"/>
                <measurement group_id="B3" value="28"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Missing information</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="9"/>
                <measurement group_id="B2" value="5"/>
                <measurement group_id="B3" value="14"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Operative vaginal delivery</title>
          <description>Number of study subjects with spontaneous, operative vaginal delivery</description>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Operative vaginal delivery</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="38"/>
                <measurement group_id="B2" value="34"/>
                <measurement group_id="B3" value="72"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Spontaneous vaginal delivery</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="75"/>
                <measurement group_id="B2" value="81"/>
                <measurement group_id="B3" value="156"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Parity</title>
          <description>Number of primiparous, multiparous study subjects</description>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Primiparous</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="76"/>
                <measurement group_id="B2" value="79"/>
                <measurement group_id="B3" value="155"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Multiparous</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="37"/>
                <measurement group_id="B2" value="36"/>
                <measurement group_id="B3" value="73"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Perineal Trauma</title>
          <description>Number of subjects with minimal, major perineal tears</description>
          <units>Participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Second degree tear or greater</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="82"/>
                <measurement group_id="B2" value="87"/>
                <measurement group_id="B3" value="169"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>First degree tear or less</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="31"/>
                <measurement group_id="B2" value="28"/>
                <measurement group_id="B3" value="59"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Maternal Body Mass Index (BMI)</title>
          <units>kg/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="29.0" spread="5.9"/>
                <measurement group_id="B2" value="29.0" spread="6.6"/>
                <measurement group_id="B3" value="29.0" spread="6.2"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Neonatal Birth Weight</title>
          <units>kilograms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="3.4" spread="0.51"/>
                <measurement group_id="B2" value="3.4" spread="0.46"/>
                <measurement group_id="B3" value="3.4" spread="0.48"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Number of Women Who Received Systemic Narcotic Analgesics in the First 24 Hours Postpartum</title>
        <time_frame>24 hours postpartum</time_frame>
        <safety_issue>No</safety_issue>
        <population>Analysis by intention to treat.</population>
        <group_list>
          <group group_id="O1">
            <title>Epidural Morphine</title>
            <description>2.5 mg dose of epidural morphine given within one hour following vaginal delivery</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>5 ml of epidural preservative-free saline given within one hour following vaginal delivery</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="113"/>
                  <measurement group_id="O2" value="115"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>The Number of Women Who Received Systemic Narcotic Analgesics in the First 24 Hours Postpartum</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="8"/>
                  <measurement group_id="O2" value="37"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Relative risk ratio estimation with 95% CI using exact methods</groups_desc>
            <non_inferiority>No</non_inferiority>
            <p_value>0.05</p_value>
            <method>Fisher Exact</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.22</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.12</ci_lower_limit>
            <ci_upper_limit>0.41</ci_upper_limit>
            <estimate_desc>Relative risk describes the risk of requiring additional analgesics in the first 24 hours postpartum with the denominator being the arm which received placebo.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to First Request for Analgesia</title>
        <description>All participants requested analgesia at least once during their hospitalization</description>
        <time_frame>Hours</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Epidural Morphine</title>
            <description>2.5 mg dose of epidural morphine given within one hour following vaginal delivery</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>5 ml of epidural preservative-free saline given within one hour following vaginal delivery</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="113"/>
                  <measurement group_id="O2" value="115"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Time to First Request for Analgesia</title>
            <description>All participants requested analgesia at least once during their hospitalization</description>
            <units>hours</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="22.9" spread="4.0"/>
                  <measurement group_id="O2" value="18.9" spread="8.0"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>0.05</p_value>
            <method>t-test, 2 sided</method>
            <method_desc>degrees of freedom 226</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-4.0</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.8</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-5.7</ci_lower_limit>
            <ci_upper_limit>-2.3</ci_upper_limit>
            <estimate_desc>The epidural morphine group represents the baseline of comparison for difference in means, with the placebo group requiring additional analgesics earlier.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Maternal Visual Analogue Scale (VAS) Score at Time of Request for First Additional Analgesic</title>
        <description>Participants were asked to indicate on a 10 cm line the point at which their perineal pain scored between one end anchored with &quot;no pain in my bottom&quot; to the other end anchored with &quot;the worst pain in my bottom that I can imagine&quot;</description>
        <time_frame>by 24 hours postpartum</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Epidural Morphine</title>
            <description>2.5 mg dose of epidural morphine given within one hour following vaginal delivery</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>5 ml of epidural preservative-free saline given within one hour following vaginal delivery</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="113"/>
                  <measurement group_id="O2" value="115"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Maternal Visual Analogue Scale (VAS) Score at Time of Request for First Additional Analgesic</title>
            <description>Participants were asked to indicate on a 10 cm line the point at which their perineal pain scored between one end anchored with &quot;no pain in my bottom&quot; to the other end anchored with &quot;the worst pain in my bottom that I can imagine&quot;</description>
            <units>scores on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="0.3" spread="1.4"/>
                  <measurement group_id="O2" value="1.6" spread="2.7"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>0.05</p_value>
            <method>t-test, 2 sided</method>
            <method_desc>degrees of freedom 212</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>1.3</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.3</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.7</ci_lower_limit>
            <ci_upper_limit>1.8</ci_upper_limit>
            <estimate_desc>Difference in VAS score when compared to the baseline group, subjects receiving epidural morphine</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Maternal Satisfaction With Perineal Pain Management</title>
        <description>5 point Likert scale asking for agreement with the statement &quot;I was satisfied with my pain relief for the pain in my bottom during the first day after delivery&quot;. Scale ranged from strongly disagree to strongly agree.</description>
        <time_frame>at 24 hours postpartum</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Epidural Morphine</title>
            <description>2.5 mg dose of epidural morphine given within one hour following vaginal delivery</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>5 ml of epidural preservative-free saline given within one hour following vaginal delivery</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="113"/>
                  <measurement group_id="O2" value="115"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Maternal Satisfaction With Perineal Pain Management</title>
            <description>5 point Likert scale asking for agreement with the statement &quot;I was satisfied with my pain relief for the pain in my bottom during the first day after delivery&quot;. Scale ranged from strongly disagree to strongly agree.</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>Strongly Disagree</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1"/>
                  <measurement group_id="O2" value="3"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Disagree</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="9"/>
                  <measurement group_id="O2" value="11"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Not sure</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="6"/>
                  <measurement group_id="O2" value="8"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Agree</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="43"/>
                  <measurement group_id="O2" value="38"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Strongly Agree</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="45"/>
                  <measurement group_id="O2" value="45"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Missing information</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="9"/>
                  <measurement group_id="O2" value="10"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>0.80</p_value>
            <p_value_desc>Fisher's exact test result did not reveal statistically significant differences between expected and real frequencies in any of the categories.</p_value_desc>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Side Effects</title>
        <description>Number of participants with pruritus, nausea and vomiting, urinary retention, drowsiness in the first 24 hours postpartum</description>
        <time_frame>at 24 hours postpartum</time_frame>
        <safety_issue>Yes</safety_issue>
      </outcome>
    </outcome_list>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Alison Macarthur</name_or_title>
      <organization>University of Toronto</organization>
      <phone>416 586 4800 ext 6632</phone>
      <email>alison.macarthur@uhn.on.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
